Onset and progression of kidney disease in type 2 diabetes among multi-ethnic Asian population

被引:10
作者
Low, Serena [1 ]
Tai, E. Shyong [2 ]
Yeoh, Lee Ying [3 ]
Liu, Yan Lun [3 ]
Liu, Jian Jun [1 ]
Tan, Kristin Hui Xian [4 ]
Fun, Sharon [5 ]
Su, Chang [1 ]
Zhang, Xiao [1 ]
Subramaniam, Tavintharan [5 ]
Sum, Chee Fang [5 ]
Lim, Su Chi [5 ]
机构
[1] Khoo Teck Puat Hosp, Clin Res Unit, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[3] Khoo Teck Puat Hosp, Dept Med, Singapore, Singapore
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[5] Khoo Teck Puat Hosp, Ctr Diabet, Singapore, Singapore
关键词
Diabetes; Chronic kidney disease; Onset; Progression; Transition; GLOMERULAR-FILTRATION-RATE; OXIDATIVE STRESS; NATURAL-HISTORY; BLOOD-PRESSURE; RENAL-DISEASE; GFR DECLINE; NEPHROPATHY; MICROALBUMINURIA; MACROALBUMINURIA; HYPERFILTRATION;
D O I
10.1016/j.jdiacomp.2016.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To elucidate the natural history of chronic kidney disease(CKD), which is defined as estimated glomerular filtration rate(eGFR) < 60 ml/min/1.73 m(2) and/or increase of urinary albumin-to-creatinine ratio (uACR) >= 30 mg/g), and to identify factors associated with its onset and progression. Methods: Prospective cohort study on individuals with T2DM attending Diabetes Centre in a regional hospital in Singapore from 2002. There were 553 patients with no pre-existing CKD for "onset" analysis and 967 patients with pre-existing CKD for "progression" analysis. Multivariable logistic regression was performed to determine risk factors of the outcomes. Results: The mean follow-up period was 5.8 years (4.5-7.1) and 53 years (3.9-6.9) for the onset and progression cohorts respectively. About 45% of individuals developed CKD and 41% had progression. Among subjects with CKD onset, albuminuria-only occurred in 75% of them. Majority of the patients remained in the same CKD risk-category during follow-up. Progression and regression occurred across all CKD-categories. Transitions to adjacent risk-category were much more likely than transitions bypassing adjacent state. Risk factors for CKD onset included baseline albuminuria, eGFR, HbA1c variability, body mass index, triglycerides and age (all P < 0.05). The predictors for CKD progression or rapid-progression included HbA1c variability, baseline albuminuria, systolic blood pressure, LDL-cholesterol, eGFR, HbA1c and ethnicity (all P < 0.05). Conclusions: Albuminuria was the first manifestation of CKD in most T2DM patients. Transition across CKD-category occurred bi-directionally, but evolved largely in a stepwise fashion. The onset and progression of CKD were predicted by multiple risk factors, some of which were modifiable. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1248 / 1254
页数:7
相关论文
共 50 条
  • [21] Quality of life in people with Type 2 diabetes; a study in a multi-ethnic clinical trial population
    Kulkarni, Shaifali
    Welsh, Paul
    Ali, Myzoon
    Petrie, John R.
    BRITISH JOURNAL OF DIABETES, 2021, 21 (02): : 210 - 215
  • [22] Predictors of anemia in a multi-ethnic chronic kidney disease population: a case-control study
    Lau, Bing Chang Vincent
    Ong, Kheng Yong
    Yap, Chun Wei
    Vathsala, Anantharaman
    How, Priscilla
    SPRINGERPLUS, 2015, 4 : 1 - 9
  • [23] Serum high-sensitivity troponin concentrations in a multi-ethnic Asian population of stable chronic kidney disease patients
    Teo, Boon Wee
    Lau, Titus
    Toh, Qi Chun
    Chua, Horng Ruey
    Wong, Weng Kin
    Haroon, Sabrina
    Subramanian, Srinivas
    Saw, Sharon
    Sethi, Sunil
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (05) : 6121 - 6123
  • [24] External validation of prognostic models for chronic kidney disease among type 2 diabetes
    Saputro, Sigit Ari
    Pattanateepapon, Anuchate
    Pattanaprateep, Oraluck
    Aekplakorn, Wichai
    McKay, Gareth J.
    Attia, John
    Thakkinstian, Ammarin
    JOURNAL OF NEPHROLOGY, 2022, 35 (06) : 1637 - 1653
  • [25] Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
    Kovesdy, Csaba P.
    Isaman, Danielle
    Petruski-Ivleva, Natalia
    Fried, Linda
    Blankenburg, Michael
    Gay, Alain
    Velentgas, Priscilla
    Folkerts, Kerstin
    CLINICAL KIDNEY JOURNAL, 2021, 14 (06) : 1657 - 1664
  • [26] HbA1c variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes
    Muthukumar, Ananya
    Badawy, Layla
    Mangelis, Anastasios
    Vas, Prashant
    Thomas, Stephen
    Gouber, Aicha
    Ayis, Salma
    Karalliedde, Janaka
    DIABETOLOGIA, 2024, 67 (09) : 1955 - 1961
  • [27] Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future
    Mallik, Ritwika
    Chowdhury, Tahseen A.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [28] Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
    DeFronzo, Ralph A.
    Bakris, George L.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07) : 1197 - 1205
  • [29] Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease
    Ryan E. K. Man
    Alvin Hong Wei Gan
    Eva K. Fenwick
    Alfred Tau Liang Gan
    Preeti Gupta
    Charumathi Sabanayagam
    Nicholas Tan
    Kah Hie Wong
    Tien Yin Wong
    Ching-Yu Cheng
    Ecosse L. Lamoureux
    Population Health Metrics, 17
  • [30] Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease
    Man, Ryan E. K.
    Gan, Alvin Hong Wei
    Fenwick, Eva K.
    Gan, Alfred Tau Liang
    Gupta, Preeti
    Sabanayagam, Charumathi
    Tan, Nicholas
    Wong, Kah Hie
    Wong, Tien Yin
    Cheng, Ching-Yu
    Lamoureux, Ecosse L.
    POPULATION HEALTH METRICS, 2019, 17 (01)